Patents by Inventor Tamara Byk

Tamara Byk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11986489
    Abstract: The present invention is directed to methods of enhancing toxicity of a glycolytic dependent compound towards a cancerous tissue and/or organ in a subject, the method being comprised of targeting the glycolytic dependent compound to the cancerous tissue and/or organ by placing oxidized regenerated cellulose (ORC) and/or oxidized cellulose (OC) in direct connection with the cancerous tissue and/or organ, and administering the glycolytic dependent compound to the subject by a systemic route.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: May 21, 2024
    Assignees: Ethicon, Inc., Omrix Biopharmaceuticals Ltd.
    Inventors: James Galloway, Tamara Byk-Tennenbaum, Erez Ilan, Lior Weissman, Sivan Doron, Eve Montia
  • Publication number: 20220088156
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 24, 2022
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Publication number: 20220054527
    Abstract: Provided are implants and a glycolytic dependent compound for use in enhancing toxicity of the glycolytic dependent compound towards a cell, tissue and/or organ e.g., a diseased cell, tissue and/or organ, wherein the implant and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
    Type: Application
    Filed: November 3, 2021
    Publication date: February 24, 2022
    Inventors: James Galloway, Tamara BYK-TENNENBAUM, Erez ILAN, Lior WEISSMAN, Sivan DORON, Eve MONTIA, Niels-Derrek Schmitz
  • Patent number: 11229688
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Grant
    Filed: October 22, 2018
    Date of Patent: January 25, 2022
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Publication number: 20210154224
    Abstract: Provided is a method of enhancing toxicity of a glycolytic dependent compound towards a cell, tissue and/or organ e.g. a diseased cell, tissue and/or organ, the method comprises contacting Oxidized Regenerated Cellulose (ORC) and/or Oxidized Cellulose (OC); and a glycolytic dependent compound with the cell, tissue and/or organ. The ORC and/or OC; and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
    Type: Application
    Filed: February 4, 2021
    Publication date: May 27, 2021
    Inventors: James Galloway, Tamara BYK-TENNENBAUM, Erez ILAN, Lior WEISSMAN, Sivan DORON, Eve MONTIA
  • Patent number: 10960021
    Abstract: Provided is a method of enhancing toxicity of a glycolytic dependent compound towards a cell, tissue and/or organ e.g. a diseased cell, tissue and/or organ, the method comprises contacting Oxidized Regenerated Cellulose (ORC) and/or Oxidized Cellulose (OC); and a glycolytic dependent compound with the cell, tissue and/or organ. The ORC and/or OC; and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: March 30, 2021
    Assignees: Omrix Biopharmaceuticals Ltd., Ethicon, Inc.
    Inventors: James Galloway, Tamara Byk-Tennenbaum, Erez Ilan, Lior Weissman, Sivan Doron, Eve Montia
  • Patent number: 10231720
    Abstract: Apparatuses and methods for delivery of fluid materials, particularly multi-part fluid materials, including modular apparatuses in which various components are maintained separately until ready for use. Each fluid component is maintained in a separate housing until mixing of the fluid components is desired. Maintaining components separately until use allows for proper filling, sterilization, packaging and storing until use.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: March 19, 2019
    Assignees: Ethicon, Inc., Omrix Biopharmaceuticals Ltd.
    Inventors: John Goodman, Jared Schneider, Kenneth M. Tamsula, Erez Ilan, Tamara Byk-Tennenbaum, John Anastasiadis
  • Publication number: 20190054156
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Application
    Filed: October 22, 2018
    Publication date: February 21, 2019
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Patent number: 10159719
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: December 25, 2018
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Patent number: 9867852
    Abstract: The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: January 16, 2018
    Assignee: Omrix Biopharmaceuticals Ltd.
    Inventors: Lior Weissman, Itai Podoler, Israel Nur, Tamara Byk-Tennenbaum
  • Publication number: 20170252372
    Abstract: The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.
    Type: Application
    Filed: May 17, 2017
    Publication date: September 7, 2017
    Inventors: Lior Weissman, Itai Podoler, Israel Nur, Tamara Byk-Tennenbaum
  • Publication number: 20170042523
    Abstract: Apparatuses and methods for delivery of fluid materials, particularly multi-part fluid materials, including modular apparatuses in which various components are maintained separately until ready for use. Each fluid component is maintained in a separate housing until mixing of the fluid components is desired. Maintaining components separately until use allows for proper filling, sterilization, packaging and storing until use.
    Type: Application
    Filed: October 28, 2016
    Publication date: February 16, 2017
    Inventors: John Goodman, Jared Schneider, Kenneth M. Tamsula, Erez ILAN, Tamara Byk-Tennenbaum, John Anastasiadis
  • Publication number: 20160067406
    Abstract: Apparatuses and methods for delivery of fluid materials, particularly multi-part fluid materials, including modular apparatuses in which various components are maintained separately until ready for use. Each fluid component is maintained in a separate housing until mixing of the fluid components is desired. Maintaining components separately until use allows for proper filling, sterilization, packaging and storing until use.
    Type: Application
    Filed: September 8, 2014
    Publication date: March 10, 2016
    Inventors: John Goodman, Jared Schneider, Kenneth M. Tamsula, Erez ILAN, Tamara Byk-Tennenbaum, John Anastasiadis
  • Publication number: 20160051641
    Abstract: The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
    Type: Application
    Filed: August 20, 2015
    Publication date: February 25, 2016
    Inventors: Yair Pilpel, Sivan Doron, Yuri Zherdev, Tamara Byk-Tennenbaum
  • Publication number: 20140179602
    Abstract: The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.
    Type: Application
    Filed: December 19, 2013
    Publication date: June 26, 2014
    Applicant: Omrix Biopharmaceuticals Ltd.
    Inventors: Lior Weissman, Itai Podoler, Israel Nur, Tamara Byk-Tennenbaum
  • Patent number: 7742216
    Abstract: Disclosed herein is an electrochromic display device comprising a pair of transparent substrates facing each other, an anode electrode and a cathode electrode respectively formed on the transparent substrates, an electrolytic layer disposed between the anode electrode and the cathode electrode, an electrochromophore layer of a nano structure formed on at least one of the anode electrode and the cathode electrode, and a redox promoter layer coated with a conductive compound, on the other electrode.
    Type: Grant
    Filed: September 6, 2007
    Date of Patent: June 22, 2010
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Chang Ho Noh, Sung Hen Cho, Ki Yong Song, Tae Rim Choi, Tamara Byk
  • Patent number: 7504199
    Abstract: Disclosed herein is a method for forming a metal pattern with a low resistivity. The method comprises the steps of: (i) coating a photocatalytic compound onto a substrate to form a photocatalytic film layer; (ii) coating a water-soluble polymeric compound onto the photocatalytic film layer to form a water-soluble polymer layer; (iii) selectively exposing the two layers to light to form a latent pattern acting as a nucleus for crystal growth; and (iv) plating the latent pattern with a metal to grow metal crystals thereon. According to the method, a multilayer wiring pattern including a low resistivity metal can be formed in a relatively simple manner at low cost, and the metals constituting the respective layers can be freely selected according to the intended application. The low resistivity metal pattern can be advantageously applied to flat panel display devices, e.g., LCDs, PDPs and ELDs.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: March 17, 2009
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Chang Ho Noh, Ki Yong Song, Jin Young Kim, Tamara Byk, Gennady A. Branitsky, Tatyana V. Gaevskaya, Valeri G. Sokolov
  • Patent number: 7488570
    Abstract: A method for forming a metal pattern with a low resistivity. The method may include the steps of: (i) coating a photocatalytic compound onto a substrate to form a photocatalytic film layer; (ii) coating a water-soluble polymeric compound onto the photocatalytic film layer to form a water-soluble polymer layer; (iii) selectively exposing the two layers to light to form a latent pattern acting as a nucleus for crystal growth; and (iv) plating the latent pattern with a metal to grow metal crystals thereon. According to the method, a multilayer wiring pattern including a low resistivity metal may be formed in a relatively simple manner at low cost, and the metals constituting the respective layers can be freely selected according to the intended application. The low resistivity metal pattern may be advantageously applied to flat panel display devices, e.g., LCDs, PDPs and ELDs.
    Type: Grant
    Filed: November 2, 2005
    Date of Patent: February 10, 2009
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Chang Ho Noh, Ki Yong Song, Jin Young Kim, Sung Hen Cho, Euk Che Hwang, Tamara Byk
  • Publication number: 20080186564
    Abstract: Disclosed herein is an electrochromic display device comprising a pair of transparent substrates facing each other, an anode electrode and a cathode electrode respectively formed on the transparent substrates, an electrolytic layer disposed between the anode electrode and the cathode electrode, an electrochromophore layer of a nano structure formed on at least one of the anode electrode and the cathode electrode, and a redox promoter layer coated with a conductive compound, on the other electrode.
    Type: Application
    Filed: September 6, 2007
    Publication date: August 7, 2008
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Chang Ho Noh, Sung Hen Cho, Ki Yong Song, Tae Rim Choi, Tamara Byk
  • Publication number: 20080044559
    Abstract: Disclosed herein is an improved method for forming a metal pattern with low contact resistance. The metal pattern may be applied to various flat panel display devices with high resolution. Further disclosed is a flat panel display using a metal pattern formed by the method.
    Type: Application
    Filed: March 27, 2007
    Publication date: February 21, 2008
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Chang Ho Noh, Tamara Byk, Sung Hen Cho, Ki Yong Song, T.V. Gaevskaya, V.G. Sokolov